Identification of radioresistance-associated proteins in human nasopharyngeal carcinoma cell lines by proteomic analysis

Cancer Biotherapy and Radiopharmaceuticals

Volumn 28, Issue 5, 2013, Pages 380-384

  Li, Ling ^a   Huang, Shiting ^a   Zhu, Xiaodong ^a   Zhou, Zhirui ^a   Liu, Yan ^a   Qu, Song ^a   Guo, Ya ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

MALDI TOF MS; nasopharyngeal carcinoma; proteomics; radioresistance; two dimensional gel electrophoresis

Indexed keywords

3 OXOACID COENZYME A TRANSFERASE; 60S ACIDIC RIBOSOMAL PROTEIN P0; ACTIN CAPPING PROTEIN; COACTOSIN LIKE PROTEIN; DEOXYURIDINE 5' TRIPHOSPHATE NUCLEOTIDOHYDROLASE; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; ELONGATION FACTOR 1; ELONGATION FACTOR 1 DELTA; F ACTIN CAPPING PROTEIN SUBUNIT BETA; GALECTIN 1; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; MEROSIN; NUCLEOPHOSMIN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PROFILIN; PROFILIN II; PROTEIN; PROTEIN C; PROTEIN DISULFIDE ISOMERASE; PROTEIN S 100; PROTEIN S100A11; RIBOSOME PROTEIN; STATHMIN; SUCCINYL COA 3 KETOACID COENZYME A TRANSFERASE 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RADIOSENSITIVITY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROTEOME; PROTEOMICS; RADIATION TOLERANCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84878879231     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1348     Document Type: Article

References (23)

1. Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. Bmc Cancer 2006;6:178.
2. Zhou X, Cui J, Macias V, et al. The progress on genetic analysis of nasopharyngeal carcinoma. Comp Funct Genomics 2007;2007:57513.
3. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC collaborative group. Metaanalysis of chemotherapy on head and neck cancer. Lancet 2000;355:949.
4. Chan AT, Teo PM, Ngan RK, et al. Concurrent chemotherapyradiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression- free survival analysis of a phase III randomized trial. J Clin Oncol 2002;20:2038.
5. Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival. J Clin Oncol 2003;21:631.
6. Lee N, Harris J, Garden AS, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009;27:3684.
7. Wong YF, Sahota DS, Cheung TH, et al. Gene expression pattern associated with radiotherapy sensitivity in cervical cancer. Cancer J 2006;12:189.
8. Ogawa K, Utsunomiya T, Mimori K, et al. Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation. Int J Oncol 2006;28:705.
9. Guo WF, Lin RX, Huang J, et al. Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis. Radiat Res 2005;164:27.
10. Higo M, Uzawa K, Kouzu Y, et al. Identification of candidate radioresistant genes in human squamous cell carcinoma cells through gene expression analysis using DNA microarrays. Oncol Rep 2005;14:1293.
11. Fukuda K, Sakakura C, Miyagawa K, et al. Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. Br J Cancer 2004;91:1543.
12. Chang JT, Chan SH, Lin CY, et al. Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther 2007;6:2271.
13. Guo Y, Zhu XD, Qu S, et al. Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks. Int J Oncol 2012;40:85.
14. Li G, Chang M, Jiang H, et al. Proteomics analysis of methylglyoxal- induced neurotoxic effects in SH-SY5Y cells. Cell Biochem Funct 2011;29:30.
15. Ouatas T, Salerno M, Palmieri D, et al. Basic and translational advances in cancer metastasis: Nm23. J Bioenerg Biomembr 2003;35:73.
16. Kaetzel DM, Zhang Q, Yang M, et al. Potential roles of 3'-5' exonuclease activity of NM23-H1 in DNA repair and malignant progression. J Bioenerg Biomembr 2006;38:163.
17. Yang M, Jarrett SG, Craven R, et al. YNK1, the yeast homolog of human metastasis suppressor NM23, is required for repair of UV radiation- and etoposide-induced DNA damage. Mutat Res 2009;660:74.
18. An R, Chu YL, Tian C, et al. Dong XP. Over-expression of nm23-H1 in HeLa cells provides cells with higher resistance to oxidative stress possibly due to raising intracellular p53 and GPX1. Acta Pharmacol Sin 2008;29:1451.
19. Kim SH, Lee SY, Park HR, et al. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer 2011;17:1864.
20. Harashima M, Niimi S, Koyanagi H. Change in annexinA3 expression by regulatory factors of hepatocyte growth in primary cultured rat hepatoeytes. Biol Pharm Bull 2006;29:1339.
21. Moss SE, Morgan RO. The annexins. Genome Biol 2004; 5:219.
22. Ernst JD, Hoye E, Blackwood RA, et al. Purification and characterization of an abundant cytosolic protein from human neutrophils that promotes Ca2 +-dependent aggregation of isolated specific granules. N Engl J Med 1990;85:1065.
23. Wu P, Zhang H, Qi L, et al. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res 2012;27:987.